The results of recent studies suggest that reduced extracellular SOD activity is closely associated with increased vascular oxidative stress, and has been implicated in the endothelial dysfunction of patients with hypertension [22], congestive heart failure, and coronary artery disease [6]. The gene discussed is SOD1; the disease is endothelial dysfunction.